Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
MannKind and NRx partner to evaluate a dry-powder ZYESAMI formulation
MannKind partnered with NRx Pharmaceuticals to evaluate the feasibility of formulating ZYESAMI (aviptadil) as a dry powder using MannKind's Technosphere platform.